The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
Open accessAbstract
PR domain containing 1 with zinc finger domain (PRDM1)/B lymphocyte–induced maturation protein 1 (BLIMP1) is a transcriptional repressor expressed in a subset of germinal center (GC) B cells and in all plasma cells, and required for terminal B cell differentiation. The BLIMP1 locus lies on chromosome 6q21-q22.1, a region frequently deleted in B cell lymphomas, suggesting that it may harbor a tumor suppressor gene. We report here that the BLIMP1 gene is inactivated by structural alterations in 24% (8 out of 34) activated B cell–like diffuse large cell lymphoma (ABC-DLBCL), but not in GC B cell–like (n = 0/37) or unclassified (n = 0/21) DLBCL. BLIMP1 alterations included gene truncations, nonsense mutations, frameshift deletions, and splice site mutations that generate aberrant transcripts encoding truncated BLIMP1 proteins. In all cases studied, both BLIMP1 alleles were inactivated by deletions or mutations. Furthermore, most non–GC type DLBCL cases (n = 20/26, 77%) lack BLIMP1 protein expression, despite the presence of BLIMP1 mRNA. These results indicate that a sizable fraction of ABC-DLBCL carry an inactive BLIMP1 gene, and suggest that the same gene is inactivated by epigenetic mechanisms in an additional large number of cases. These findings point to a role for BLIMP1 as a tumor suppressor gene, whose inactivation may contribute to lymphomagenesis by blocking post–GC differentiation of B cells toward plasma cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Hans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Rosenwald, A., Wright, G., Leroy, K., Yu, X., Gaulard, P., Gascoyne, R. D., Chan, W. C., Zhao, T., Haioun, C., Greiner, T. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031074 · Cited by 1,101
Shaffer, A. L., Lin, K.-I., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Calame, K., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00335-7 · Cited by 1,047
Wright, G., Tan, B., Rosenwald, A., Hurt, E. H., Wiestner, A., & Staudt, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732008100 · Cited by 1,040
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S. K., Küppers, R., & Dalla-Favera, R. (2001) · Nature · doi:10.1038/35085588 · Cited by 1,032
Self-citationShapiro-Shelef, M., Lin, K.-I., McHeyzer-Williams, L. J., Liao, J., McHeyzer-Williams, M. G., & Calame, K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00267-x · Cited by 839
Monti, S. (2005) · Blood · doi:10.1182/blood-2004-07-2947 · Cited by 820
Self-citationTurner, C. A., Mack, D. H., & Davis, M. M. (1994) · Cell · doi:10.1016/0092-8674(94)90321-2 · Cited by 761
Shaffer, A. L., Yu, X., He, Y., Boldrick, J., Chan, E. P., & Staudt, L. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00020-0 · Cited by 724
Repression of c- myc Transcription by Blimp-1, an Inducer of Terminal B Cell Differentiation
Lin, Y., Wong, K.-K., & Calame, K. (1997) · Science · doi:10.1126/science.276.5312.596 · Cited by 429
Lymphoid Malignancies: the dark side of B-cell differentiation
Shaffer, A. L., Rosenwald, A., & Staudt, L. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri953 · Cited by 419
Commitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo
Angelin-Duclos, C., Cattoretti, G., Lin, K.-I., & Calame, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5462 · Cited by 337
Chromosomal and Gene Amplification in Diffuse Large B-Cell Lymphoma
Rao, P. H., Houldsworth, J., Dyomina, K., Parsa, N. Z., Cigudosa, J. C., Louie, D. C., Popplewell, L., Offit, K., Jhanwar, S. C., & Chaganti, R. S. K. (1998) · Blood · doi:10.1182/blood.v92.1.234.413k22_234_240 · Cited by 331
Self-citationTranscriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase
Yu, J., Angelin-Duclos, C., Greenwood, J., Liao, J., & Calame, K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2592-2603.2000 · Cited by 327
Abramson, J. S., & Shipp, M. A. (2005) · Blood · doi:10.1182/blood-2005-02-0687 · Cited by 208
Self-citation6q deletions define distinct clinico-pathologic subsets of non- Hodgkin's lymphoma
Offit, K., Parsa, N., Gaïdano, G., Filippa, D., Louie, D. C., Pan, D., Jhanwar, S. C., Dalla‐Favera, R., & CHAGANTI, R. S. K. (1993) · Blood · doi:10.1182/blood.v82.7.2157.2157 · Cited by 187
Self-citationDeletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma
Gaïdano, G., Hauptschein, R. S., Parsa, N., Offit, K., Rao, P., Lenoir, G., Knowles, D., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1992) · Blood · doi:10.1182/blood.v80.7.1781.1781 · Cited by 187
Self-citationGyőry, I., Fejér, G., Ghosh, N., Seto, E., & Wright, K. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3125 · Cited by 144
PRDM1/Blimp‐1 is expressed in human B‐lymphocytes committed to the plasma cell lineage
Cattoretti, G., Angelin‐Duclos, C., Shaknovich, R., Zhou, H., Wang, D., & Alobeid, B. (2005) · The Journal of Pathology · doi:10.1002/path.1752 · Cited by 125
Keller, A., & Maniatis, T. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.1940 · Cited by 113
Messika, E. J., Lu, P. S., Sung, Y., Yao, T., Chi, J., Chien, Y., & Davis, M. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.515 · Cited by 90
Cited by
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
The generation of antibody-secreting plasma cells
Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., & Corcoran, L. M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3795 · Cited by 1,454
Initial genome sequencing and analysis of multiple myeloma
Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,433
Self-citationMutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Compagno, M., Lim, W. K., Grunn, A., Nandula, S. V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., et al. (2009) · Nature · doi:10.1038/nature07968 · Cited by 1,038
Self-citationAnalysis of the coding genome of diffuse large B-cell lymphoma
Pasqualucci, L., Trifonov, V., Fabbri, G., Ma, J., Rossi, D., Chiarenza, A., Wells, V. A., Grunn, A., Messina, M., Elliot, O., et al. (2011) · Nature Genetics · doi:10.1038/ng.892 · Cited by 971
Self-citation
Metadata
- Authors
- Pasqualucci, L., Compagno, M., Houldsworth, J., Monti, S., Grunn, A., Nandula, S. V., Aster, J. C., Murty, V. V., Shipp, M. A., & Dalla-Favera, R.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-02-20
- Volume
- 203
- Issue
- 2
- Pages
- 311-317
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2142766411
- Cited by
- 370
- References
- 25
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.